BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22863263)

  • 1. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?
    Fabrizi F; Dixit V; Messa P
    J Viral Hepat; 2012 Sep; 19(9):601-7. PubMed ID: 22863263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
    Fabrizi F; Takkouche B; Lunghi G; Dixit V; Messa P; Martin P
    J Viral Hepat; 2007 Oct; 14(10):697-703. PubMed ID: 17875004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
    Fabrizi F; Dixit V; Messa P
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):244-254. PubMed ID: 30910601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of observational studies: hepatitis C and survival after renal transplant.
    Fabrizi F; Martin P; Dixit V; Messa P
    J Viral Hepat; 2014 May; 21(5):314-24. PubMed ID: 24716634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and Its Metabolic Complications in Kidney Disease.
    Fabrizi F; Donato FM; Messa P
    Ann Hepatol; 2017 November-December,; 16(6):851-861. PubMed ID: 29055921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C treatment in patients with kidney disease.
    Fabrizi F; Aghemo A; Messa P
    Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.
    Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1271-7. PubMed ID: 15606388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances on hepatitis C virus in dialysis population.
    Fabrizi F; Messa P; Martin P
    Kidney Blood Press Res; 2014; 39(4):260-71. PubMed ID: 25171295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in dialysis patients with HCV infection.
    Fabrizi F; Messa P; Martin P
    Int J Artif Organs; 2009 Aug; 32(8):473-81. PubMed ID: 19844890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Fabrizi F; Donato FM; Messa P
    Ann Hepatol; 2018; 17(3):364-391. PubMed ID: 29735788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C-related liver disease in dialysis patients.
    Fabrizi F; Dixit V; Messa P; Martin P
    Contrib Nephrol; 2012; 176():42-53. PubMed ID: 22310780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies.
    Petta S; Maida M; Macaluso FS; Barbara M; Licata A; Craxì A; Cammà C
    Gastroenterology; 2016 Jan; 150(1):145-155.e4; quiz e15-6. PubMed ID: 26386298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
    Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
    Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.
    Kwon E; Cho JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kim HJ; Park JM; Lee JE; Jung HY; Choi JY; Park SH; Kim CD; Kim YL;
    PLoS One; 2015; 10(8):e0135476. PubMed ID: 26263373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.
    Ohsawa M; Kato K; Tanno K; Itai K; Fujishima Y; Okayama A; Turin TC; Onoda T; Suzuki K; Nakamura M; Kawamura K; Akiba T; Sakata K; Fujioka T
    J Epidemiol; 2011; 21(6):491-9. PubMed ID: 22001541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies].
    Fabrizi F; Messa P
    G Ital Nefrol; 2012; 29 Suppl 56():S78-84. PubMed ID: 23059944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatitis C virus infection in patients on long-term hemodialysis.
    Khokhar N; Alam AY; Naz F; Mahmud SN
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):326-8. PubMed ID: 15924834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus and death risk in hemodialysis patients.
    Kalantar-Zadeh K; Kilpatrick RD; McAllister CJ; Miller LG; Daar ES; Gjertson DW; Kopple JD; Greenland S
    J Am Soc Nephrol; 2007 May; 18(5):1584-93. PubMed ID: 17429053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Fabrizi F; Verdesca S; Messa P; Martin P
    Dig Dis Sci; 2015 Dec; 60(12):3801-13. PubMed ID: 26195311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.